PT97964A - Processo para a producao de composicoes farmaceuticas de somatostatina de reabsorcao aumentada, e sua utilizacao - Google Patents
Processo para a producao de composicoes farmaceuticas de somatostatina de reabsorcao aumentada, e sua utilizacao Download PDFInfo
- Publication number
- PT97964A PT97964A PT97964A PT9796491A PT97964A PT 97964 A PT97964 A PT 97964A PT 97964 A PT97964 A PT 97964A PT 9796491 A PT9796491 A PT 9796491A PT 97964 A PT97964 A PT 97964A
- Authority
- PT
- Portugal
- Prior art keywords
- somatostatin
- acid
- cholanic acid
- cholanic
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909013448A GB9013448D0 (en) | 1990-06-15 | 1990-06-15 | Pharmaceutical resorption-improved somatostatin compositions,their preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT97964A true PT97964A (pt) | 1992-03-31 |
Family
ID=10677720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97964A PT97964A (pt) | 1990-06-15 | 1991-06-14 | Processo para a producao de composicoes farmaceuticas de somatostatina de reabsorcao aumentada, e sua utilizacao |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0462071B1 (enExample) |
| JP (1) | JPH04230223A (enExample) |
| KR (1) | KR920000323A (enExample) |
| AU (1) | AU7833191A (enExample) |
| CA (1) | CA2044511A1 (enExample) |
| CH (1) | CH683069A5 (enExample) |
| DE (1) | DE4119062A1 (enExample) |
| ES (1) | ES2067906T3 (enExample) |
| FI (1) | FI912868A7 (enExample) |
| FR (1) | FR2663227B1 (enExample) |
| GB (2) | GB9013448D0 (enExample) |
| HU (1) | HUT59007A (enExample) |
| IE (1) | IE912010A1 (enExample) |
| IL (1) | IL98477A0 (enExample) |
| IT (1) | IT1297205B1 (enExample) |
| LU (1) | LU87952A1 (enExample) |
| NO (1) | NO912271L (enExample) |
| NZ (1) | NZ238522A (enExample) |
| PT (1) | PT97964A (enExample) |
| TW (1) | TW226332B (enExample) |
| ZA (1) | ZA914583B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9203769D0 (en) * | 1992-02-21 | 1992-04-08 | Sandoz Ltd | Improvements in or relating to organic compounds |
| CA2145302C (en) * | 1993-07-30 | 2008-10-28 | Masahiko Dohi | Peptide proteinaceous drug nasal powder composition |
| GB9417524D0 (en) * | 1994-08-31 | 1994-10-19 | Cortecs Ltd | Pharmaceutical compositions |
| JPH11292787A (ja) * | 1995-08-15 | 1999-10-26 | Asahi Chem Ind Co Ltd | 生理活性ペプチドを含有する経粘膜投与製剤 |
| NZ522036A (en) * | 2000-04-19 | 2004-04-30 | Borody Thomas J | Compositions and therapies for hyperlipidaemia-associated disorders |
| US20030083241A1 (en) * | 2001-11-01 | 2003-05-01 | Young Charles W. | Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation |
| AU2006314444C1 (en) * | 2005-11-21 | 2018-01-04 | Novartis Ag | Neuroendocrine tumor treatment using mTOR inhibitors |
| WO2007062469A1 (en) * | 2005-12-01 | 2007-06-07 | Flinders Technologies Pty Ltd | Methods and compositions for preventing and/or treating pancreatitis |
| HRP20170929T1 (hr) | 2008-09-17 | 2017-09-22 | Chiasma Inc. | Farmaceutski pripravci i odgovarajući postupci za isporuku |
| GB0817969D0 (en) | 2008-10-01 | 2008-11-05 | Axcess Ltd | Pharmaceutical composition |
| AU2016215350B2 (en) | 2015-02-03 | 2021-11-25 | Amryt Endo, Inc. | Method of treating diseases |
| US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL68769A (en) * | 1983-05-23 | 1986-02-28 | Hadassah Med Org | Pharmaceutical compositions containing insulin for oral administration |
| HU198626B (en) * | 1986-05-27 | 1989-11-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient |
| JPS632932A (ja) * | 1986-06-23 | 1988-01-07 | Teijin Ltd | 経鼻投与用粉末状組成物 |
| HU203204B (en) * | 1987-09-15 | 1991-06-28 | Sandoz Ag | Process for producing suppository containing calcitonin and taurocholic acid |
-
1990
- 1990-06-15 GB GB909013448A patent/GB9013448D0/en active Pending
-
1991
- 1991-06-03 HU HU911849A patent/HUT59007A/hu unknown
- 1991-06-10 DE DE4119062A patent/DE4119062A1/de not_active Withdrawn
- 1991-06-11 GB GB9112509A patent/GB2244918B/en not_active Expired - Fee Related
- 1991-06-12 CH CH1755/91A patent/CH683069A5/de not_active IP Right Cessation
- 1991-06-13 IE IE201091A patent/IE912010A1/en unknown
- 1991-06-13 FI FI912868A patent/FI912868A7/fi not_active Application Discontinuation
- 1991-06-13 AU AU78331/91A patent/AU7833191A/en not_active Abandoned
- 1991-06-13 ES ES91810450T patent/ES2067906T3/es not_active Expired - Lifetime
- 1991-06-13 NZ NZ238522A patent/NZ238522A/en unknown
- 1991-06-13 NO NO91912271A patent/NO912271L/no unknown
- 1991-06-13 EP EP91810450A patent/EP0462071B1/en not_active Expired - Lifetime
- 1991-06-13 IL IL98477A patent/IL98477A0/xx unknown
- 1991-06-13 CA CA002044511A patent/CA2044511A1/en not_active Abandoned
- 1991-06-13 LU LU87952A patent/LU87952A1/fr unknown
- 1991-06-14 JP JP3143095A patent/JPH04230223A/ja active Pending
- 1991-06-14 PT PT97964A patent/PT97964A/pt not_active Application Discontinuation
- 1991-06-14 ZA ZA914583A patent/ZA914583B/xx unknown
- 1991-06-14 KR KR1019910010018A patent/KR920000323A/ko not_active Withdrawn
- 1991-06-14 FR FR9107345A patent/FR2663227B1/fr not_active Expired - Fee Related
- 1991-06-17 IT IT91RM000430A patent/IT1297205B1/it active IP Right Grant
- 1991-06-18 TW TW080104684A patent/TW226332B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| LU87952A1 (fr) | 1993-01-15 |
| ITRM910430A1 (it) | 1992-12-17 |
| FI912868A0 (fi) | 1991-06-13 |
| GB9112509D0 (en) | 1991-07-31 |
| JPH04230223A (ja) | 1992-08-19 |
| ITRM910430A0 (it) | 1991-06-17 |
| AU7833191A (en) | 1992-01-02 |
| NO912271L (no) | 1991-12-16 |
| CH683069A5 (de) | 1994-01-14 |
| TW226332B (enExample) | 1994-07-11 |
| CA2044511A1 (en) | 1991-12-16 |
| NO912271D0 (no) | 1991-06-13 |
| ZA914583B (en) | 1993-02-24 |
| FI912868L (fi) | 1991-12-16 |
| FR2663227A1 (fr) | 1991-12-20 |
| ES2067906T3 (es) | 1995-04-01 |
| HU911849D0 (en) | 1991-12-30 |
| IT1297205B1 (it) | 1999-08-03 |
| NZ238522A (en) | 1993-10-26 |
| GB2244918A (en) | 1991-12-18 |
| IL98477A0 (en) | 1992-07-15 |
| GB9013448D0 (en) | 1990-08-08 |
| HUT59007A (en) | 1992-04-28 |
| GB2244918B (en) | 1994-06-15 |
| EP0462071A1 (en) | 1991-12-18 |
| DE4119062A1 (de) | 1991-12-19 |
| FR2663227B1 (fr) | 1995-04-28 |
| FI912868A7 (fi) | 1991-12-16 |
| EP0462071B1 (en) | 1995-02-01 |
| IE912010A1 (en) | 1991-12-18 |
| KR920000323A (ko) | 1992-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5089482A (en) | Pharmaceutical compositions for nasal administration containing steroid hormones and dimethyl-β-cyclodextrin | |
| KR930003332B1 (ko) | 항이뇨제 ddavp의 경구 투여용 제제의 제조방법 | |
| US6426340B1 (en) | Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-FUDCA) | |
| Plaisancié et al. | Luminal peptide YY-releasing factors in the isolated vascularly perfused rat colon | |
| BRPI0908292B1 (pt) | Métodos e composições para administração oral de exenatida | |
| PT97964A (pt) | Processo para a producao de composicoes farmaceuticas de somatostatina de reabsorcao aumentada, e sua utilizacao | |
| Konturek | Somatostatin and the gastrointestinal secretions | |
| JPH0678238B2 (ja) | インシュリンを含む薬剤組成物 | |
| JP2010270125A (ja) | 機能性消化不良および/または過敏性腸症候群の治療用の医薬組成物ならびにその中の物質の新規な使用 | |
| JP2007210995A (ja) | アヘン剤拮抗物質およびカルシウム塩を含む薬剤組成物、エンドルフィン介在病状の治療のためのこれらの使用法 | |
| BRPI0821373B1 (pt) | composições farmacêuticas contendo ao menos um princípio ativo protéico protegido de enzimas digestivas | |
| GB2190838A (en) | Pharmaceutical compositions containing polypeptides | |
| EP1406649B1 (en) | Use of substances with oxytocin activity against climacteric disorders | |
| HU206633B (en) | Process for producing pharmaceutical compositions for treating arthritis containing somatostatine analogues or derivatives thereof | |
| US4151276A (en) | Method of suppressing gastric acid secretion by the oral administration of calcitonin | |
| BR112020018362A2 (pt) | Composição de glp-1 para tratar obesidade e controle de peso | |
| JPH08295637A (ja) | 口腔部局所投与剤 | |
| US4470974A (en) | Gastric cytoprotection with L-363,586 | |
| TW201922249A (zh) | 二羧酸化合物與磷吸附劑之組合 | |
| Usadel | Hormonal and nonhormonal cytoprotective effect by somatostatins | |
| Shi et al. | Restoration of gallbladder contractility after withdrawal of long-term octreotide therapy in acromegalic patients | |
| KR20030094377A (ko) | 에어로졸화 인슐린을 사용한 2형 당뇨병의 예방 방법 | |
| Kalfarentzos et al. | Gallbladder contraction after hormonal manipulations in normal subjects and patients under total parenteral nutrition. | |
| JPH01501708A (ja) | アミノ酸の経鼻投与 | |
| Meier et al. | Somatostatin: Characterization and the role of analogues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19911114 |
|
| FC3A | Refusal |
Effective date: 19980805 |